Circulating magnesium status is associated with type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a long-term cohort study

AbstractBackground Low serum magnesium levels predict cardiovascular and all-cause mortality in patients with typ 2 diabetes. Setting Outpatient clinic of obesity central hospital. Objectives To assess long-term alterations circulating status after Roux-en-Y gastric bypass (RYGB) surgery associations remission type diabetes (T2D). Methods Retrospective analysis 5-year outcomes plasma (p-Mg) glucometabolic statuses who underwent primary RYGB completed the annual follow-up program. Data were investigated from 84 without 62 T2D before RYGB, showed either prolonged (n = 30), temporary 16), or no 16) surgery. Results Body mass indexes similar T2D, irrespective remission. The not achieving longer durations; higher glucose levels; more intensive antidiabetic drug treatment, including insulin; significantly lower p-Mg concentrations (.73 [±.08] mmol/L compared .80–.82 [±.07] mmol/L, respectively; P < .01) than groups showing After increased similarly, by 10–12% surgery, remission; however, nonremission group did reach registered other follow-up. reached .82 (.09) .87 (.06) .88 (.08) (P .05), respectively, a history Conclusion increments started an inferior level seen